Back to search results

Oral Iron Dosing for Premature Infants (IQONic)

This study, called IQONic, is looking at the best way to give oral iron (ferrous sulfate) to premature infants who are at risk for iron deficiency and anemia. Researchers want to see if giving 6 mg/kg of oral iron every other day works as well as giving it every day to help infants reach a healthy iron level by 36 weeks after conception. This is important because iron helps with blood production and brain development. The study is for premature infants born between 26 and 32 weeks of gestation who are in the hospital and starting oral iron. The goal is to enroll 100 infants. The current status of the study is unclear.

Study design
This is an interventional pilot trial aiming to enroll 100 premature infants. It compares two groups: one receiving oral iron every other day and another receiving it daily.
What's involved
Not specified in the trial record.
Compensation
Not stated in the trial record.
Follow-up
The primary outcome is measured between 1 week and 36 weeks after conception.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.

NCT06555315

Pilot Trial Investigating Every Other Day Dosing of Oral Iron in Premature Infants (IQONic)

UNKNOWN
NAAges 26–32InterventionalSupportive care
CHRISTUS Health
~100 participants
Updated 2024-08-15 on ClinicalTrials.gov
What's tested:6 mg/kg of oral iron as ferrous sulfate administered every other day.6 mg/kg of oral iron as ferrous sulfate administered every day.

At a glance

Recruiting sites
1 of 1 listed site is recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
Determine if daily versus EOD oral iron at the same dose per kilogram per day will achieve similar incidence of iron replete status at 36 weeks PMA.
Measured over 1 Week-36 Weeks

Conditions

Very Low Birth Weight Infant
Premature Infants
Anemia of Prematurity
Iron Deficiency, Anaemia in Children
Extremely Low Birth Weight

Explore related trials

Anemia of PrematurityExtremely Low Birth WeightIron DeficiencyPremature infantVery low birth weight infant

NCT06555315

Where you'd take part

This study runs at 1 site. They're the same protocol — you choose where, and that choice sets who your contact draft is addressed to.

  • CHRISTUS Children's

    San Antonio, Texasstudy coordinator listed

    Recruiting

Sites open and close at different times, so the status above is per site — it can differ from the study's overall status.

Study leadership

  • Pratik K Parikh, MD · PRINCIPAL_INVESTIGATOR · CHRISTUS Health
  • Richelle L Homo, MD · PRINCIPAL_INVESTIGATOR · CHRISTUS Health; Brooke Army Medical Center

Who to contact

Rosario Ocampo
[email protected]
210-704-4996
Email the study team

Opens a ready-to-send draft in your own email app — review before sending.

Want this trial checked against your situation?

Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.

Check eligibility for this trial ~2 min · HIPAA-protected · delete anytime
Eligibility criteria

Inclusion

Children (Minor \< 18 years of age)
Neonates
Hospitalized
Premature infants who are on full enteral feeds and are started on oral iron
Premature infants who completed 26 0/7 to 32 6/7 weeks' gestation at birth

What this trial measures

  • Determine if daily versus EOD oral iron at the same dose per kilogram per day will achieve similar incidence of iron replete status at 36 weeks PMA.1 Week-36 Weeks

    The iron replete status will be measured by reticulocyte hemoglobin (Ret-Hb) between EOD and daily iron supplementation.